Endometrial cancer is a type of cancer that begins in the uterus. More specifically, it is a type of cancer that starts in the endometrium, the layer of tissue that forms the inner lining of the uterus.
More than 66,000 people in the United States are diagnosed with a form of uterine cancer each year, and roughly 90 percent of those cases are endometrial cancer. This makes endometrial cancer the most common gynecologic cancer in the U.S.
What is endometrial cancer?
Like other forms of cancer, endometrial cancer begins with mutations to the DNA of normal cells. These mutations result in cells that divide and multiply uncontrollably, disrupting the normal function of organs, invading nearby tissues, and causing other problems. With endometrial cancers, these mutations occur in the cells that make up the endometrium.
What are the symptoms of endometrial cancer?
The most common symptom of endometrial cancer is abnormal or unexpected vaginal bleeding (especially after age 40 and/or after menopause). Lower abdominal pain, pelvic cramping, feeling a mass, and unexplained weight loss are other possible symptoms.
Symptoms like these should always be evaluated by a healthcare provider as soon as possible.
Have you ever had a blood transfusion or organ transplant before 1992?
Is endometrial cancer caused by hormonal changes?
While the exact cause of endometrial cancer is not known, hormonal imbalances are known to play an important role in its development—specifically, an imbalance between the female sex hormones estrogen and progesterone.
Here is a simplified explanation:
- Estrogen stimulates the growth of endometrial tissue inside the uterus (among many other functions of the female reproductive system).
- Progesterone helps counter estrogen’s effects on endometrial tissue. When there is too much estrogen without enough progesterone to balance it out, unopposed estrogen (sometimes called estrogen dominance) can occur.
- Unopposed estrogen results in unregulated production of endometrial tissue. This is believed to create an environment where endometrial cancer is more likely to occur.
Again, the exact cause of endometrial cancer is not known, and there are still unanswered questions about why it occurs in some people and not others.
Unopposed estrogen is also associated with breast cancer, uterine fibroids, endometriosis, polycystic ovarian syndrome (PCOS), and endometrial hyperplasia (a precancerous thickening of the endometrium).
What are the risk factors for endometrial cancer?
A risk factor is anything associated with an increased risk of developing cancer. Many of the risk factors associated with endometrial cancer are related to hormonal imbalances. Risk factors include:
- Age. The majority of cases are diagnosed in women between the ages of 45 and 74. However, endometrial cancers (as well as less common types of uterine cancers) occur in people across many different age groups.
- Age at menstruation and menopause. Beginning menstruation before the age of 12 and/or having late-onset menopause (after age 55) increases the number of menstrual cycles in a person’s life. A higher number of menstrual cycles is associated with an increased risk of endometrial cancer.
- Obesity. Being overweight or obese puts a person at a higher risk of having endometrial cancer. Excess body fat increases the levels of estrogen in the body, which can stimulate the growth of endometrium.
- Previous cancers and cancer treatments. Breast cancer, ovarian cancer, pelvic cancers that have been treated with radiation, and certain hormone therapies used to treat or prevent breast cancer are associated with an increased risk of endometrial cancer.
- Medical history. This includes a history of PCOS, type 2 diabetes, hypertension, infertility, and endometrial hyperplasia.
- Family history. A family history of endometrial cancer, ovarian cancer, and/or colorectal cancer is a risk factor for endometrial cancer. This includes Lynch Syndrome, or hereditary nonpolyposis colorectal cancer (HNPCC), a genetic disorder that increases the risk of some types of cancers.
- Estrogen therapy. These are medications that contain estrogen without progesterone, which are sometimes used to treat menopausal symptoms. Systemic estrogen-only therapies, which affect the whole body, should only be used when the person taking the medication does not have a uterus (for example, if they have undergone a hysterectomy).
- Race. The risk of endometrial cancer varies by race and ethnicity. For example, the incidence of endometrial cancer is higher in white women, but Black women and Hispanic women are more likely to be diagnosed at younger ages and with more aggressive forms of cancer.
While it is helpful to know the risk factors for endometrial cancer, your best source of information about your health will always be your healthcare provider.
Sources (20)
- MedlinePlus. Endometrial Cancer. March 31, 2024.
- American Cancer Society. Cancer Facts & Figures 2023-2026. All accessed March 3, 2026.
- American Cancer Society. Key Statistics for Endometrial Cancer. January 14, 2026.
- National Cancer Institute. SEER. Cancer Stat Facts: All Cancer Sites Combined. Accessed March 3, 2026.
- Mahdy H, Vadakekut ES, Crotzer D. Endometrial Cancer. 2024 Apr 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
- Cancer Research UK. How does cancer start? Accessed March 3, 2026.
- American Cancer Society. Signs and Symptoms of Endometrial Cancer. February 28, 2025.
- Johns Hopkins Health. Estrogen's Effects on the Female Body. Accessed March 3, 2026.
- U.S. Department of Veterans Affairs Whole Health Library. Estrogen Dominance. July 9, 2025.
- M. Montanino Oliva, R. Gambioli, et al. Unopposed estrogens: current and future perspectives. European Review for Medical and Pharmacological Sciences, 2022. Vol. 26, No. 8.
- American Cancer Society. Endometrial Cancer Risk Factors. December 23, 2015.
- Yale Medicine. Endometrial Hyperplasia. Accessed March 3, 2026.
- MacMillan Cancer Support. Causes and risk factors. October 1, 2025.
- National Cancer Institute. Risk Factors for Cancer. December 23, 2015.
- Biagetti B, Puig-Domingo M. Age-Related Hormones Changes and Its Impact on Health Status and Lifespan. Aging Dis. 2023 Jun 1;14(3):605-620.
- National Cancer Institute. Obesity and Cancer. January 28, 2025.
- Johns Hopkins Medicine. Endometrial Cancer. Accessed March 3, 2026.
- Memorial Sloan Kettering Cancer Center. Endometrial (Uterine) Cancer Risk Factors & Prevention. Accessed March 3, 2026.
- MedlinePlus. Tamoxifen. January 15, 2018.
- American Cancer Society. Menopausal Hormone Therapy and Cancer Risk. January 22, 2026.